Shares of Pfizer rose modestly Tuesday after the drugmaker forecast a drop in revenue and earnings in 2026, driven in part by weaker Covid-19 product sales.Pfizer expects adjusted per-share earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback